SterileAtlas Marketplaces

DiscoveryAcademic Preclinical Labs Process Dev (PDO)CDMOs

ClinicalCROs Clinical Sites Ethics / IRB Central Labs

QualityPharmacovigilance Regulatory Engineering Consultants

SupplySuppliers Equipment Packaging

DistributionLogistics Distribution Specialty Pharmacy

AccessPayers PBM

CapitalInvestors IP & Legal

SterileAtlasIntelligence Mission Control

Loading…

SterileAtlas

One marketplace for the entire drug lifecycle — global sterile pharmaceutical & biotech manufacturing intelligence.

Marketplaces

All 22 marketplaces
CDMOs
CROs
Clinical trial sites
Consultants

Opportunities

Projects, jobs & leads
Open projects
Jobs
Consulting leads

Platform

Pricing
About us
List your company
Mission Control

© 2026 SterileAtlas · Capability scores are deterministic, rules-based — not AI.

About us Terms Usage Policy Disclosures Compliance Community guidelines Privacy Cookies Refunds DPA Trust & security

Data shown across the platform is illustrative and unverified — not for vendor qualification or regulatory use.

Discovery & Development

CDMOs

Contract development & manufacturing

16

CDMOs listed

Drug substance, drug product, advanced-therapy and sterile fill-finish manufacturers — ranked on transparent capability scores.

SearchFaceted, over real records CompareSide-by-side scorecards Post an RFxGet qualified responses CollaborateRun it in a shared room AI assistantYour organisation, this market

Scores are deterministic, rules-based — not AI.

MarketplacesCDMOs

16 providers

Sort

Manufacturing breadth Advanced therapy Fill-finish capacity Quality & compliance Regulatory reach Capacity & scale Name (A–Z)

Technology platforms

Microbial fermentation3 Continuous manufacturing2 Single-use systems2 Spray drying2 Viral vector production2 000 L; microbial drug substance 150 L-401 000 L; small-molecule API1 000+ L and 450 KL reactor capacity at Bidar1 AAV1 Activ-Blister solutions1 ADC conjugation and fill-finish; high-containment handling of cytotoxics and high-potent compounds (company states preparation of anticancer products with an OEL lower than 10 ng/m31 advanced therapy medicinal products1 analytical and particle science development; API manufacturing with reactors from lab scale to 101 and a dedicated high-potency injectable line (OEL 10 ng/m3).1 and non-cytotoxics up to OEB 6); liposomal and lipid-based formulations; micro- and nano-emulsions; peptides1 antibody-drug conjugates1

Availability

Accepting new projects100 Verified0

Annual capacity

Any annual capacity ≥ 10k batches / yr ≥ 50k batches / yr ≥ 250k batches / yr ≥ 1M batches / yr

Cleanroom suites

Any suite count ≥ 3 suites ≥ 8 suites ≥ 20 suites ≥ 40 suites

Facilities

Any facility count ≥ 5 facilities ≥ 10 facilities ≥ 20 facilities

Company headcount

Any headcount ≥ 2,500 employees ≥ 5,000 employees ≥ 10,000 employees

Modalities

Small molecules46 Biologics (drug substance)44 mRNA16 HPAPI40 Peptides24 Oligonucleotides16 Plasmid DNA6

Advanced therapy

Cell therapy21 Gene therapy18 Viral vectors19 CAR-T4

Dosage forms

Sterile injectables67 Ophthalmics4 Vaccines19 Oral solids42 Liquids41 Semi-solids6 Lyophilization50

Fill-finish

Vial filling58 Prefilled syringe49 Cartridge filling20 Isolator30 RABS14 Blow-fill-seal11

Services

Process development93 Clinical manufacturing80 Commercial manufacturing89 Packaging51 Tech transfer54

Special handling

Controlled substances7 Combination products7

Quality & regulatory

GMP certified0 Annex 10 Data-integrity program0

Quality score

Any quality score ≥ 85 quality score ≥ 90 quality score ≥ 92 quality score

On-time delivery

Any on-time rate ≥ 94% on-time delivery ≥ 95% on-time delivery ≥ 96% on-time delivery

Inspection pass rate

Any pass rate ≥ 95% inspection pass ≥ 97% inspection pass ≥ 98% inspection pass

Ownership

Private33 Subsidiary27 PE-backed25 Public15

Provider type

Biologics CDMO28 CDMO23 Integrated CDMO22 Sterile Fill-Finish21 API Manufacturer6

Region

Europe40 North America30 Asia17 Japan5 China4 United States2 Oceania1 South America1

Location

United States27

United Kingdom4

Showing 1 of 16Clear filters DMPK Oligonucleotides Process development

SAI

Sai Life Sciences

Integrated CDMO · Hyderabad, India

22breadth

HPAPIPeptides

ADV 0FF 00 suites

AvailableFocused